DDT/DDE and Infant Exposure
The article by L6pez-Carrillo et al. (1) , which discusses the public health implications of using DDT in Mexico, is a welcome contribution to the literature. DDT is a public health concern not only in the countries still using the chemical but also in those countries that have restricted, phased out, or banned use of the chemical. Presently, it is difficult to conclude if DDT contributes to breast cancer incidence, and the lack of complete confidence in our understanding of the relationship between this xenoestrogen and breast cancer should not prevent us from finding alternatives to DDT that have less public health impact. L6pez-Carrillo et al. (1) Although a direct comparison between the 10-day-old mice used in these studies and 10-day-old humans cannot be made, the sequence of events of brain development between humans and rodents is quite similar (6,7) That is, nerve production, myelin formation, receptor development, etc., are events that occur in the same order in rodents and humans (7). At day 10, mice are in their last stages of neuron production for the hippocampus and cerebellum (8). Antimitotic drugs are much more toxic if exposure occurs earlier in development when more neurons are being produced (9, 10 reported elsewhere, subjects born in Mexico had significantly elevated levels of DDT and DDE (p < 0.01) in breast milk compared to levels found in subjects born in the United States (1, 13, 14) .
For each cohort sampled, an infant DDT intake level was determined using the breast milk value that included twothirds of that particular cohort. For a 5-kg infant consuming 1 kg breast milk daily, infant DDT intake levels for the cohorts were in the range of 0.7-3.5 x 10-3 mg/kg/day. These results do not include two outliers from the Mexico-born nonconsumer cohort who had DDT/DDE levels greater than two standard deviations from the mean. Our infant exposure values derived from the cohort data (excluding outliers) were more than two orders of magnitude below the administered dose used by Eriksson et al. (2) (3) (4) . The two women (considered outliers) had DDT breast milk levels that correspond to the elevated levels observed in women living in Mexico. These DDT breast milk levels would expose breast-feeding infants each day to levels that are less than two orders of magnitude from the one-time administered dose given to neonatal mice.
Although DDT may contribute to an increase in breast cancer, exposure to DDT may also produce neurological and developmental endpoints of significance that require consideration. The study conducted in Washington State and data on breast milk DDT levels obtained from women in Mexico indicate that infants may be exposed to potentially deleterious levels of these compounds through breast milk. With DDT in our environment, various populations can still be exposed to sufficiently elevated DDT levels in the United States that warrant concern. Also, due to the influx of Mexico In summary, the EPA will rightly draw more on improved understanding of the mechanism by which toxic effects are produced. Over the years it has been recognized that the ultimate value of toxicological information relates to its use in the development of formal risk or safety assessments. Thus, a broad array of research is focused on the development of mechanistic information that will have value in assessing the potential human health risk of environmental pollutants and consumer products and assessing the safety ofpharmaceuticals.
From this research have emerged significant advances in our understanding of the mechanism of carcinogenesis, which justifies EPA's effort to rethink cancer calculations. Among these advances are the following:
Significant developments in science of how humans metabolize cancer-causing substances. Most 
